![]() |
![]() |
Teisinis statusas
Patentas galioja
(51) | INT.CL. | A61K 38/00 | (2006.01) |
A61K 38/12 | (2006.01) | ||
C07D 487/04 | (2006.01) |
(11) | Patento numeris | 2340029 |
(13) | Dokumento rūšis | T |
(96) | Europos patento paraiškos numeris | 09813360.6 |
Europos patento paraiškos padavimo data | 2009-09-10 | |
(97) | Europos patento paraiškos paskelbimo data | 2011-07-06 |
(45) | Paskelbimo apie Europos patento išdavimą data | 2014-03-05 |
(46) | Apibrėžties vertimo paskelbimo data | 2014-07-25 |
(86) | Numeris | PCT/US2009/005082 |
Data | 2009-09-10 |
(87) | Numeris | WO 2010/030359 |
Data | 2010-03-18 |
(30) | Numeris | Data | Šalis |
209689 P | 2009-03-10 | US | |
191725 P | 2008-09-11 | US |
(72) |
KU, Yiyin, US
MCDANIEL, Keith, F., US
CHEN, Hui-ju, US
SHANLEY, Jason, P., US
KEMPF, Dale, J., US
GRAMPOVNIK, David, J., US
SUN, Ying, US
LIU, Dong, US
GAI, Yonghua, US
OR, Yat, Sun, US
WAGAW, Sable, H., US
ENGSTROM, Ken, US
GRIEME, Tim, US
SHEIKH, Ahmad, US
MEI, Jianzhang, US
|
(73) |
Enanta Pharmaceuticals, Inc.,
500 Arsenal Street, Watertown, MA 02472,
US
AbbVie Manufacturing Management Unlimited Company , 70 Sir John Rogerson's Quay, Dublin 2, IE |
(74) |
Otilija KLIMAITIENĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
(54) | Makrocikliniai hepatito C serino proteazės inhibitoriai |
MACROCYCLIC HEPATITIS C SERINE PROTEASE INHIBITORS |
Mokėjimo data | Galiojimo metai | Suma | |
2024-08-09 | 16 | 347.00 EUR |
2025-09-10 |